Media 280723

CTO Mr Craig Weller said on Aqua Phase studies revealing the absorption of CBD as more than 4 times greater than CBD in oil:
Bod has been sweating on the PK study for months. It needed to show improved bioavailability of 30% for the deal to proceed, it exceeded by a factor of 10, what this means is that if we ingest 100mg of CBD in oil, we will normally absorb 6-8% of the dose. With Aqua Phase, the CBD absorption is 32% This means we can either get a better response to the CBD or otherwise we can reduce the Aqua Phase dose – giving potentially less side effects and providing CBD raw material savings.
Researchers probe the potential impact of medicinal cannabis on Long COVID symptoms
20 Jan 2022
Published by: Yahoo! Finance
UK trial to examine medical cannabis as treatment for long covid
18 Jan 2022
Published by: Cannabis Health News
Bod to launch UK clinical trial into medicinal cannabis efficacy on long COVID
17 Jan 2022
Published by: Business News Australia
Proposed clinical trial will assess medical cannabis for ‘long Covid’
17 Jan 2022
Published by: Canex
Bod Australia to start trial of medicinal cannabis for long-COVID in UK
17 Jan 2022
Published by: Clinical Trials Arena
Bod Australia (ASX:BDA) to undertake insomnia trial with Woolcock Institute – The Market Herald
22 Sep 2021
Published by: The Market Herald
Swisse vitamins owner targets Aussie cannabis stock
16 Jul 2021
Published by: The Australian Financial Review